426 related articles for article (PubMed ID: 32724793)
1. A Comprehensive Review of Cutaneous Manifestations Associated with COVID-19.
Rahimi H; Tehranchinia Z
Biomed Res Int; 2020; 2020():1236520. PubMed ID: 32724793
[TBL] [Abstract][Full Text] [Related]
2. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.
Galván Casas C; Català A; Carretero Hernández G; Rodríguez-Jiménez P; Fernández-Nieto D; Rodríguez-Villa Lario A; Navarro Fernández I; Ruiz-Villaverde R; Falkenhain-López D; Llamas Velasco M; García-Gavín J; Baniandrés O; González-Cruz C; Morillas-Lahuerta V; Cubiró X; Figueras Nart I; Selda-Enriquez G; Romaní J; Fustà-Novell X; Melian-Olivera A; Roncero Riesco M; Burgos-Blasco P; Sola Ortigosa J; Feito Rodriguez M; García-Doval I
Br J Dermatol; 2020 Jul; 183(1):71-77. PubMed ID: 32348545
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous manifestations in COVID-19: Lessons learned from current evidence.
Suchonwanit P; Leerunyakul K; Kositkuljorn C
J Am Acad Dermatol; 2020 Jul; 83(1):e57-e60. PubMed ID: 32339706
[No Abstract] [Full Text] [Related]
4. [Are there cutaneous manifestations of SARS-CoV-2?].
Drerup KA; Gläser R
Hautarzt; 2020 Sep; 71(9):734-736. PubMed ID: 32778924
[No Abstract] [Full Text] [Related]
5. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
[TBL] [Abstract][Full Text] [Related]
6. COVID toes and other cutaneous manifestations of COVID-19.
Rose-Sauld S; Dua A
J Wound Care; 2020 Sep; 29(9):486-487. PubMed ID: 32924822
[No Abstract] [Full Text] [Related]
7. [Cutaneous manifestations in COVID-19: current state].
Jazouly ME; Chahboun FZ; Chiheb S
Pan Afr Med J; 2020; 35(Suppl 2):132. PubMed ID: 33193947
[No Abstract] [Full Text] [Related]
8. Dermatologic manifestations and complications of COVID-19.
Gottlieb M; Long B
Am J Emerg Med; 2020 Sep; 38(9):1715-1721. PubMed ID: 32731141
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous Manifestations of COVID-19: Characteristics, Pathogenesis, and the Role of Dermatology in the Pandemic.
Alam M; Lewis W; Harp J; Steele K; Rosenbach M; Micheletti RG
Cutis; 2021 Apr; 107(4):209-215. PubMed ID: 34096848
[TBL] [Abstract][Full Text] [Related]
10. Appearance of skin rash in pediatric patients with COVID-19: Three case presentations.
Bursal Duramaz B; Yozgat CY; Yozgat Y; Turel O
Dermatol Ther; 2020 Jul; 33(4):e13594. PubMed ID: 32412681
[No Abstract] [Full Text] [Related]
11. Cutaneous lesions in a patient with COVID-19: are they related?
Ahouach B; Harent S; Ullmer A; Martres P; Bégon E; Blum L; Tess O; Bachmeyer C
Br J Dermatol; 2020 Aug; 183(2):e31. PubMed ID: 32353170
[No Abstract] [Full Text] [Related]
12. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature.
Sachdeva M; Gianotti R; Shah M; Bradanini L; Tosi D; Veraldi S; Ziv M; Leshem E; Dodiuk-Gad RP
J Dermatol Sci; 2020 May; 98(2):75-81. PubMed ID: 32381430
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue.
Marzano AV; Cassano N; Genovese G; Moltrasio C; Vena GA
Br J Dermatol; 2020 Sep; 183(3):431-442. PubMed ID: 32479680
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous Manifestations in Adult Patients with COVID-19 and Dermatologic Conditions Related to the COVID-19 Pandemic in Health Care Workers.
Mawhirt SL; Frankel D; Diaz AM
Curr Allergy Asthma Rep; 2020 Oct; 20(12):75. PubMed ID: 33047260
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and the Skin.
Catalá Gonzalo A; Galván Casas C
Actas Dermosifiliogr (Engl Ed); 2020; 111(6):447-449. PubMed ID: 32401723
[No Abstract] [Full Text] [Related]
16. Thrombotic occlusive vasculopathy in a skin biopsy from a livedoid lesion of a patient with COVID-19.
Llamas-Velasco M; Muñoz-Hernández P; Lázaro-González J; Reolid-Pérez A; Abad-Santamaría B; Fraga J; Daudén-Tello E
Br J Dermatol; 2020 Sep; 183(3):591-593. PubMed ID: 32407552
[No Abstract] [Full Text] [Related]
17. Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19).
Carrascosa JM; Morillas V; Bielsa I; Munera-Campos M
Actas Dermosifiliogr (Engl Ed); 2020 Nov; 111(9):734-742. PubMed ID: 32882184
[TBL] [Abstract][Full Text] [Related]
18. Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.
Hughes M; Rogers S; Lepri G; Bruni C; Matucci-Cerinic M
Br J Dermatol; 2020 Sep; 183(3):596-598. PubMed ID: 32460349
[No Abstract] [Full Text] [Related]
19. Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): Histologic, immunofluorescence, and immunohistochemical study of 17 cases.
Kanitakis J; Lesort C; Danset M; Jullien D
J Am Acad Dermatol; 2020 Sep; 83(3):870-875. PubMed ID: 32502585
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): A brief review.
Tang K; Wang Y; Zhang H; Zheng Q; Fang R; Sun Q
Dermatol Ther; 2020 Jul; 33(4):e13528. PubMed ID: 32383234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
